EnteraSense
EnteraSense develops PillSense, an ingestible capsule technology designed to detect upper gastrointestinal bleeding in real-time using advanced optical sensors. The device wirelessly transmits diagnostic data to an external receiver to assist healthcare professionals in the triage process and reduce the need for urgent endoscopies. The company operates under a licensed technology agreement from Brigham and Women’s Hospital and Harvard Medical School to serve the gastroenterology and emergency medicine markets.
Funding summary
- Total raised
- €3.5M
- Funding rounds
- 1
Investors in EnteraSense
Investors on record for EnteraSense. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like EnteraSense?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors